EUDA

EUDA Health Holdings Limited (EUDA) | Rumor.io

EUDA Health Holdings

EUDA

Attention (50-day avg)0%

Attention rank (50-day avg)#4,562

Bullish sentiment (50-day avg)100%

Price to earnings ratio30

Market capitalization48.5M

Earnings per share-1.4

Dividend yield (TTM)—

Revenue (annual)6.8M

Net income (annual)-2.8M

Social

What share of all stock conversation is about EUDA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% +0

May 6

$EUDA halted up with low volume.
$EUDA price dropped from $25 to $12, with speculation about market makers preloading.
$EUDA has a 1.5M float and is subject to a recent reverse stock split.

Generated by AI

Sentiment

Of the messages about EUDA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100%	100% 0	94.92% +3.18
Bearish	0%	0%	0% 0	5.08% -3.18

Bullish· Apr 30

$EUDA has shown a significant increase of +20.8% from $12.00 to $14.49, indicating a strong bullish trend.
The stock is expected to continue its upward momentum, with potential for a 10x increase, making it an attractive opportunity for investors.
$EUDA's price can fluctuate rapidly, with the potential for significant gains or losses in a short period of time, making it a high-risk, high-reward investment.

Bearish· Apr 23

$EUDA's price action is overheated, with a surge past the 50D MA, and a high risk of a massive flush if it loses the $15 support level.
The sell volume for $EUDA is huge, indicating a strong bearish sentiment.
The company's reverse split in March suggests that it is struggling, which may be a major concern for investors.

Generated by AI

Topics

Of the messages about EUDA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	83.61%
Analysts	—	—	—	0%
Controversies	—	—	—	0.33%
Earnings	—	—	—	0%
Macro	—	—	—	0.33%
Technical Analysis	—	—	—	15.74%

Announcements· Dec 24

EUDA Health Holdings Limited (EUDA) has launched a comprehensive stem cell therapy platform and its first clinic in Shenzhen, accelerating its longevity strategy.
The launch of the platform and clinic has driven a significant technical breakout, with EUDA's price surging to $2.7100 and up 41.15%.
The company's strategic pivot is expected to improve capital allocation, with clinical trial catalysts appearing imminent and a potential target price of $4.09.

Technical Analysis· Apr 29

The technical analysis suggests that EUDA is a midday runner with a pattern that has developed over the last two days, with a stop-loss in place to monitor the situation.
The stock has broken through resistance at $13.60, surging 35.00% to $16.20, with volume of 408.3K confirming the breakout and a catalyst driving momentum towards a potential target of $23.00.
The primary driver's energy is fully engaged, with major momentum kicking in, and the initial target set near $20, indicating a strong bullish sentiment for EUDA.

Generated by AI

Community

Of the messages about EUDA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	60%	60%	60%	14.77%
Newcomers	40%	40%	40%	85.23%

Apr 30

The newcomer has observed a significant increase in the price of EUDA Health Holdings Limited, rising from $12.00 to $14.49, representing a +20.8% gain.
The newcomer has discovered a professional stock analyst who shares daily stock picks, including EUDA, MODD, SAGT, and potentially other high-yield stocks.
The newcomer believes that learning from the analyst's approach could be beneficial, as investing is an ongoing process that requires continuous learning and improvement.

Generated by AI

SINGAPORE, AUGUST, Aug. 26, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based distributor of third-party wellness and non-invasive healthcare products and services in Singapore, Malaysia and China, as well as property management services in Singapore, today announced that its subsidiary, Melana International Pte. Ltd. (“Melana”), was recognised as one of the winners of the SME100 Awards 2026 Singapore, organised by Business Media In

1mo agoYahoo Finance

EUDA Health details cell therapy collaboration agreement

2mo agoInvesting.com

EUDA Health, GO POSB, Shenzhen Innovation Plan Cell Therapy Collaboration

EUDA Health (EUDA) said Thursday that GO POSB Organoids and Shenzhen Innovation Immunotechnology pla

2mo agoYahoo Finance

EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products

SINGAPORE, July 30, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today provided important additional details of the integrated cell therapy program to be pursued under its recently announced non-binding Memorandum of Understanding (MOU) with GO POSB Organoids Pte Ltd (“GO POSB”) and Shenzhen Innovation Imm

2mo agoYahoo Finance

EUDA Health signs MOU for stem cell cancer therapy development

2mo agoInvesting.com

Also Discussed

Investors talking about EUDA also mention

#	Name	Attention
1	MKDWELL Tech Inc.MKDW	0%+0
2	Inno Holdings Inc.INHD	0%new
3	Design Therapeutics, Inc.DSGN	0%0
4	Texas Community Bancshares, Inc. Common StockTCBS	0%0
5	Roma Green Finance LimitedROMA	0%0
6	LanzaTech Global Inc. Common StockLNZA	0%new
7	ICZOOM Group Inc. Class A Ordinary SharesIZM	0%0
8	Avanos Medical Inc.AVNS	0%0
9	Distribution Solutions Group, Inc.DSGR	0%0
10	OneConstruction Group Ltd.ONEG	0%0

EUDA Health Holdings Limited

Real Estate
Real Estate Services

EUDA Health Holdings Limited is a Singapore-based health technology and services company focused on non-invasive healthcare, preventive care, and wellness solutions across Southeast Asia and China. Its current offerings center on a digital healthcare ecosystem that uses artificial intelligence to assess patient histories, support triage, connect patients with clinicians, and coordinate care from wellness and prevention through urgent care, treatment, and aftercare. The company also provides specialized medical services, including bioenergy cabin therapy packages, stem cell therapy services through third-party treatment centers, and holistic wellness consumer products and services. In addition, EUDA Health Holdings Limited operates property management services for residential, commercial, and retail properties, creating a diversified business model that combines healthcare and real estate-related operations. The company is headquartered in Singapore and serves both individual and corporate clients.

Website

Location

60 Kaki Bukit Place

Singapore, 415979

Singapore

Social

What share of all stock conversation is about EUDA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% +0

May 6

$EUDA halted up with low volume.
$EUDA price dropped from $25 to $12, with speculation about market makers preloading.
$EUDA has a 1.5M float and is subject to a recent reverse stock split.

Generated by AI

Sentiment

Of the messages about EUDA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100%	100% 0	94.92% +3.18
Bearish	0%	0%	0% 0	5.08% -3.18

Bullish· Apr 30

$EUDA has shown a significant increase of +20.8% from $12.00 to $14.49, indicating a strong bullish trend.
The stock is expected to continue its upward momentum, with potential for a 10x increase, making it an attractive opportunity for investors.
$EUDA's price can fluctuate rapidly, with the potential for significant gains or losses in a short period of time, making it a high-risk, high-reward investment.

Bearish· Apr 23

$EUDA's price action is overheated, with a surge past the 50D MA, and a high risk of a massive flush if it loses the $15 support level.
The sell volume for $EUDA is huge, indicating a strong bearish sentiment.
The company's reverse split in March suggests that it is struggling, which may be a major concern for investors.

Generated by AI

Topics

Of the messages about EUDA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	83.61%
Analysts	—	—	—	0%
Controversies	—	—	—	0.33%
Earnings	—	—	—	0%
Macro	—	—	—	0.33%
Technical Analysis	—	—	—	15.74%

Announcements· Dec 24

EUDA Health Holdings Limited (EUDA) has launched a comprehensive stem cell therapy platform and its first clinic in Shenzhen, accelerating its longevity strategy.
The launch of the platform and clinic has driven a significant technical breakout, with EUDA's price surging to $2.7100 and up 41.15%.
The company's strategic pivot is expected to improve capital allocation, with clinical trial catalysts appearing imminent and a potential target price of $4.09.

Technical Analysis· Apr 29

The technical analysis suggests that EUDA is a midday runner with a pattern that has developed over the last two days, with a stop-loss in place to monitor the situation.
The stock has broken through resistance at $13.60, surging 35.00% to $16.20, with volume of 408.3K confirming the breakout and a catalyst driving momentum towards a potential target of $23.00.
The primary driver's energy is fully engaged, with major momentum kicking in, and the initial target set near $20, indicating a strong bullish sentiment for EUDA.

Generated by AI

Community

Of the messages about EUDA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	60%	60%	60%	14.77%
Newcomers	40%	40%	40%	85.23%

Apr 30

The newcomer has observed a significant increase in the price of EUDA Health Holdings Limited, rising from $12.00 to $14.49, representing a +20.8% gain.
The newcomer has discovered a professional stock analyst who shares daily stock picks, including EUDA, MODD, SAGT, and potentially other high-yield stocks.
The newcomer believes that learning from the analyst's approach could be beneficial, as investing is an ongoing process that requires continuous learning and improvement.

Generated by AI

EUDA Health Holdings

Social

May 6

Sentiment

Bullish· Apr 30

Bearish· Apr 23

Topics

Announcements· Dec 24

Technical Analysis· Apr 29

Community

Apr 30

News

12 Health Care Stocks Moving In Monday's Intraday Session

EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore

EUDA Health details cell therapy collaboration agreement

EUDA Health, GO POSB, Shenzhen Innovation Plan Cell Therapy Collaboration

EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products

EUDA Health signs MOU for stem cell cancer therapy development

Also Discussed

EUDA Health Holdings Limited

Company Information

Location

News

12 Health Care Stocks Moving In Monday's Intraday Session

EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore

EUDA Health details cell therapy collaboration agreement

EUDA Health, GO POSB, Shenzhen Innovation Plan Cell Therapy Collaboration

EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products

EUDA Health signs MOU for stem cell cancer therapy development

Also Discussed

Social

May 6

Sentiment

Bullish· Apr 30

Bearish· Apr 23

Topics

Announcements· Dec 24

Technical Analysis· Apr 29

Community

Apr 30